IP Library Granted Patent US 9,463,169
Granted Patent B2
US 9,463,169 · App. 14/238,980 · Granted Oct 11, 2016

Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation

Inventors: Mark L. Heiman (Indianapolis, IN); Dean P. Stull (Longmont, CO); Justin W. Peno (Saint Francisville, LA)
Assignee: MicroBiome Therapeutics, LLC
A61K31/155A23L29/212A23L33/00A23L33/105A23L33/21A61K9/0095A61K31/047A61K31/716A61K31/718A61K31/733A61K36/00A61K36/45A61K38/28A23V2002/00A61K9/0031A61K9/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,463,169
App. No.
14/238,980
Granted
Oct 11, 2016
Kind
B2
Abstract

A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.

Claims (28)

1. A human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation and having fewer than 200 usable Calories per therapeutic dose, comprising:

a) at least about 3 g of purified inulin

b) at least about 2 g of a dietary β-glucan extract; and

c) blueberry pomace, or an extract thereof, comprising at least about 700 mg of dietary polyphenol compounds.

2. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein the blueberry pomace, or an extract thereof, comprises at least about 4.7 g of dietary polyphenol compounds.

3. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein

the dietary β-glucan is extracted from a member of the group consisting of: baker's yeast, oat, barley, wheat, fungi, mushrooms, bacteria, and combinations thereof.

4. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein

the dietary β-glucan includes β-glucan extracted from oat.

5. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein the inulin is agave inulin.

6. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein the dietary β-glucan includes β-glucan extracted from wheat.

7. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein the dietary β-glucan includes β-glucan extracted from barley.

8. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein the blueberry pomace extract is present.

9. The human gastrointestinal microbiome modulating food supplement of claim 1 , comprising fewer than 150 usable Calories per therapeutic dose.

10. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein:

a) inulin is present in an amount of 4-40% by weight;

b) the dietary β-glucan is present in an amount of 2-21% by weight; and

c) the dietary polyphenol compounds are present in an amount of 0.5-9% by weight.

11. The human gastrointestinal microbiome modulating food supplement of claim 1 , wherein:

a) inulin is present in an amount of 6.5-28% by weight;

b) the dietary β-glucan is present in an amount of 3.5-14% by weight; and

c) the dietary polyphenol compounds are present in an amount of 1-6% by weight.

12. The human gastrointestinal microbiome modulating food supplement of claim 1 , formulated as: a food preparation, medical food, beverage, suspension, powder, bar, smoothie, yogurt, shake, capsule, or tablet.

13. A medical food composition, comprising: the human gastrointestinal microbiome modulating food supplement of claim 1 .

14. A human gastrointestinal microbiome modulating medical food composition, for dietary management in a diabetic patient that is being treated with metformin, comprising:

a) at least about 3 g of purified inulin;

b) at least about 2 g of a β-glucan extracted from oat; and

c) blueberry pomace, or an extract thereof, comprising at least about 700 mg of a dietary polyphenol compound.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2020
From: MICROBIOME THERAPEUTICS, LLC
To: THE NATURE'S BOUNTY CO.
Reel/Frame 052429/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2014
From: HEIMAN, MARK L; STULL, DEAN P; PENO, JUSTIN W
To: NUME HEALTH LLC
Reel/Frame 032559/0119 →
CHANGE OF NAME Recorded Mar 31, 2014
From: NUME HEALTH LLC
To: MICROBIOME THERAPEUTICS LLC
Reel/Frame 032568/0774 →
Continuity (2)
Provisional Application 61524524 · Aug 17, 2011
Related Publication 20140294997A1 · Oct 2, 2014